Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$3.03 - $5.32 $40,914 - $71,835
13,503 Added 29.14%
59,842 $218,000
Q1 2022

May 13, 2022

BUY
$4.66 - $7.66 $62,737 - $103,126
13,463 Added 40.95%
46,339 $235,000
Q4 2021

Feb 11, 2022

BUY
$6.82 - $17.8 $71,685 - $187,095
10,511 Added 47.0%
32,876 $251,000
Q3 2021

Nov 10, 2021

BUY
$13.62 - $19.48 $304,611 - $435,670
22,365 New
22,365 $331,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.